Cargando…

Docosahexaenoic acid-containing choline phospholipid modulates LPS-induced neuroinflammation in vivo and in microglia in vitro

BACKGROUND: Neuroinflammatory processes are considered a double-edged sword, having both protective and detrimental effects in the brain. Microglia, the brain’s resident innate immune cells, are a key component of neuroinflammatory response. There is a growing interest in developing drugs to target...

Descripción completa

Detalles Bibliográficos
Autores principales: Fourrier, Célia, Remus-Borel, Julie, Greenhalgh, Andrew D., Guichardant, Michel, Bernoud-Hubac, Nathalie, Lagarde, Michel, Joffre, Corinne, Layé, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571638/
https://www.ncbi.nlm.nih.gov/pubmed/28838312
http://dx.doi.org/10.1186/s12974-017-0939-x
_version_ 1783259383979835392
author Fourrier, Célia
Remus-Borel, Julie
Greenhalgh, Andrew D.
Guichardant, Michel
Bernoud-Hubac, Nathalie
Lagarde, Michel
Joffre, Corinne
Layé, Sophie
author_facet Fourrier, Célia
Remus-Borel, Julie
Greenhalgh, Andrew D.
Guichardant, Michel
Bernoud-Hubac, Nathalie
Lagarde, Michel
Joffre, Corinne
Layé, Sophie
author_sort Fourrier, Célia
collection PubMed
description BACKGROUND: Neuroinflammatory processes are considered a double-edged sword, having both protective and detrimental effects in the brain. Microglia, the brain’s resident innate immune cells, are a key component of neuroinflammatory response. There is a growing interest in developing drugs to target microglia and control neuroinflammatory processes. In this regard, docosahexaenoic acid (DHA), the brain’s n-3 polyunsaturated fatty acid, is a promising molecule to regulate pro-inflammatory microglia and cytokine production. Several works reported that the bioavailability of DHA to the brain is higher when DHA is acylated to phospholipid. In this work, we analyzed the anti-inflammatory activity of DHA-phospholipid, either acetylated at the sn-1 position (AceDoPC, a stable form thought to have superior access to the brain) or acylated with palmitic acid at the sn-1 position (PC-DHA) using a lipopolysaccharide (LPS)-induced neuroinflammation model both in vitro and in vivo. METHODS: In vivo, adult C57Bl6/J mice were injected intravenously (i.v.) with either AceDoPC or PC-DHA 24 h prior to LPS (i.p.). For in vitro studies, immortalized murine microglia cells BV-2 were co-incubated with DHA forms and LPS. AceDoPC and PC-DHA effect on brain or BV-2 PUFA content was assessed by gas chromatography. LPS-induced pro-inflammatory cytokines interleukin IL-1β, IL-6, and tumor necrosis factor (TNF) α production were measured by quantitative PCR (qPCR) or multiplex. IL-6 receptors and associated signaling pathway STAT3 were assessed by FACS analysis and western-blot in vitro. RESULTS: In vivo, a single injection of AceDoPC or PC-DHA decreased LPS-induced IL-6 production in the hippocampus of mice. This effect could be linked to their direct effect on microglia, as revealed in vitro. In addition, AceDoPC or PC-DHA reduced IL-6 receptor while only AceDoPC decreased IL-6-induced STAT3 phosphorylation. CONCLUSIONS: These results highlight the potency of administered DHA—acetylated to phospholipids—to rapidly regulate LPS-induced neuroinflammatory processes through their effect on microglia. In particular, both IL-6 production and signaling are targeted by AceDoPC in microglia.
format Online
Article
Text
id pubmed-5571638
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55716382017-08-30 Docosahexaenoic acid-containing choline phospholipid modulates LPS-induced neuroinflammation in vivo and in microglia in vitro Fourrier, Célia Remus-Borel, Julie Greenhalgh, Andrew D. Guichardant, Michel Bernoud-Hubac, Nathalie Lagarde, Michel Joffre, Corinne Layé, Sophie J Neuroinflammation Research BACKGROUND: Neuroinflammatory processes are considered a double-edged sword, having both protective and detrimental effects in the brain. Microglia, the brain’s resident innate immune cells, are a key component of neuroinflammatory response. There is a growing interest in developing drugs to target microglia and control neuroinflammatory processes. In this regard, docosahexaenoic acid (DHA), the brain’s n-3 polyunsaturated fatty acid, is a promising molecule to regulate pro-inflammatory microglia and cytokine production. Several works reported that the bioavailability of DHA to the brain is higher when DHA is acylated to phospholipid. In this work, we analyzed the anti-inflammatory activity of DHA-phospholipid, either acetylated at the sn-1 position (AceDoPC, a stable form thought to have superior access to the brain) or acylated with palmitic acid at the sn-1 position (PC-DHA) using a lipopolysaccharide (LPS)-induced neuroinflammation model both in vitro and in vivo. METHODS: In vivo, adult C57Bl6/J mice were injected intravenously (i.v.) with either AceDoPC or PC-DHA 24 h prior to LPS (i.p.). For in vitro studies, immortalized murine microglia cells BV-2 were co-incubated with DHA forms and LPS. AceDoPC and PC-DHA effect on brain or BV-2 PUFA content was assessed by gas chromatography. LPS-induced pro-inflammatory cytokines interleukin IL-1β, IL-6, and tumor necrosis factor (TNF) α production were measured by quantitative PCR (qPCR) or multiplex. IL-6 receptors and associated signaling pathway STAT3 were assessed by FACS analysis and western-blot in vitro. RESULTS: In vivo, a single injection of AceDoPC or PC-DHA decreased LPS-induced IL-6 production in the hippocampus of mice. This effect could be linked to their direct effect on microglia, as revealed in vitro. In addition, AceDoPC or PC-DHA reduced IL-6 receptor while only AceDoPC decreased IL-6-induced STAT3 phosphorylation. CONCLUSIONS: These results highlight the potency of administered DHA—acetylated to phospholipids—to rapidly regulate LPS-induced neuroinflammatory processes through their effect on microglia. In particular, both IL-6 production and signaling are targeted by AceDoPC in microglia. BioMed Central 2017-08-24 /pmc/articles/PMC5571638/ /pubmed/28838312 http://dx.doi.org/10.1186/s12974-017-0939-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Fourrier, Célia
Remus-Borel, Julie
Greenhalgh, Andrew D.
Guichardant, Michel
Bernoud-Hubac, Nathalie
Lagarde, Michel
Joffre, Corinne
Layé, Sophie
Docosahexaenoic acid-containing choline phospholipid modulates LPS-induced neuroinflammation in vivo and in microglia in vitro
title Docosahexaenoic acid-containing choline phospholipid modulates LPS-induced neuroinflammation in vivo and in microglia in vitro
title_full Docosahexaenoic acid-containing choline phospholipid modulates LPS-induced neuroinflammation in vivo and in microglia in vitro
title_fullStr Docosahexaenoic acid-containing choline phospholipid modulates LPS-induced neuroinflammation in vivo and in microglia in vitro
title_full_unstemmed Docosahexaenoic acid-containing choline phospholipid modulates LPS-induced neuroinflammation in vivo and in microglia in vitro
title_short Docosahexaenoic acid-containing choline phospholipid modulates LPS-induced neuroinflammation in vivo and in microglia in vitro
title_sort docosahexaenoic acid-containing choline phospholipid modulates lps-induced neuroinflammation in vivo and in microglia in vitro
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571638/
https://www.ncbi.nlm.nih.gov/pubmed/28838312
http://dx.doi.org/10.1186/s12974-017-0939-x
work_keys_str_mv AT fourriercelia docosahexaenoicacidcontainingcholinephospholipidmodulateslpsinducedneuroinflammationinvivoandinmicrogliainvitro
AT remusboreljulie docosahexaenoicacidcontainingcholinephospholipidmodulateslpsinducedneuroinflammationinvivoandinmicrogliainvitro
AT greenhalghandrewd docosahexaenoicacidcontainingcholinephospholipidmodulateslpsinducedneuroinflammationinvivoandinmicrogliainvitro
AT guichardantmichel docosahexaenoicacidcontainingcholinephospholipidmodulateslpsinducedneuroinflammationinvivoandinmicrogliainvitro
AT bernoudhubacnathalie docosahexaenoicacidcontainingcholinephospholipidmodulateslpsinducedneuroinflammationinvivoandinmicrogliainvitro
AT lagardemichel docosahexaenoicacidcontainingcholinephospholipidmodulateslpsinducedneuroinflammationinvivoandinmicrogliainvitro
AT joffrecorinne docosahexaenoicacidcontainingcholinephospholipidmodulateslpsinducedneuroinflammationinvivoandinmicrogliainvitro
AT layesophie docosahexaenoicacidcontainingcholinephospholipidmodulateslpsinducedneuroinflammationinvivoandinmicrogliainvitro